Extracellular Acidosis leads to the Development of a senescent-like Phenotype and molecular Reprogramming of human Melanoma Cells (2018) Böhme I, Boßerhoff AK Conference contribution CYLD - A potential Mediator of tissue-specific Melanoma Metastasis (2018) Schott M, de Jel MM, Boßerhoff AK, Kuphal S Conference contribution SiRNA-Knockdown einer neuen Argonaute2 Spleißvariante verringert die tumorigenen Eigenschaften von Melanomzellen. (2018) Linck L, Boßerhoff AK Conference contribution, Abstract of a poster Positionspapier: Telemedizin in der Berufsdermatologie - Aktueller Stand und Perspektiven (2018) Elsner P, Bauer A, Diepgen TL, Drexler H, Fartasch M, John SM, Schliemann S, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Anti-PD-1 Therapy in SUFU mutant Patients with Gorlin-Goltz Syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Tumor-suppressing Plasma extracellular Vesicles (pEV) from Melanoma Patients are secreted by Liver Cells and PBMC (2018) Baur A, Lee JH, Eberhardt M, Blume K, Schuler G, Vera González J Conference contribution The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution S2k-Leitlinie zum Gebrauch von Präparationen zur lokalen Anwendung auf der Haut (Topika) (2018) Wohlrab J, Staubach P, Augustin M, Eisert L, Huenerbein A, Nast A, Reimann H, et al. Journal article